Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by TexRitteron Dec 18, 2017 9:35pm
121 Views
Post# 27183671

RE:RE:RE:RE:CMED Buying HIP, What Were They Smoking?

RE:RE:RE:RE:CMED Buying HIP, What Were They Smoking?Basically I think a remaining third of the shareholders are required (two thirds I believe basically are required) if allowed to vote moving forward (courts), and if the lockup shares in place are deemed valid. Zettl himself and any other company executive not wanting to receive their golden handshake probably hold 15 - 25 % of the total shares, so with very poor math, there are 38% for, 15 - 25% against, and the independent shareholders remaining - 38% - 47%  - of that group, Aurora would need to obtain many/most of them, to reach 66 and two thirds. My understanding and again poor math. I have no doubt that any independent shareholder that takes the time to do an objective analysis will vote for the Aurora deal, so much of it depends on how many shares are controlled by Zettl and any other Cmed execs who want too keep their positions. The positive news for those wanting the takeover is that the execs who were not happy and resigned would control decent numbers, although their shares may already be included in those indicated as locked up (the 38% already accounted for).


Bullboard Posts